BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8747440)

  • 1. Macular edema in chronic Vogt-Koyanagi-Harada syndrome.
    Rutzen AR; Ortega-Larrocea G; Frambach DA; Rao NA
    Retina; 1995; 15(6):475-9. PubMed ID: 8747440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease.
    Yamaguchi Y; Otani T; Kishi S
    Am J Ophthalmol; 2007 Aug; 144(2):260-5. PubMed ID: 17533104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoreceptor Cell Injury Starts in the Initial Stage of Vogt-Koyanagi-Harada Disease.
    Zhu R; Zhang J; Qiao L; Zhang Y; Gu X; Yang L
    Ocul Immunol Inflamm; 2018; 26(6):934-942. PubMed ID: 28323511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of macular cone photoreceptors in Vogt-Koyanagi-Harada disease.
    Nakamura T; Hayashi A; Oiwake T
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):387-394. PubMed ID: 29264653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posterior sub-Tenon's injections of corticosteroids in uveitis patients with cystoid macular edema.
    Jennings T; Rusin MM; Tessler HH; Cunha-Vaz JG
    Jpn J Ophthalmol; 1988; 32(4):385-91. PubMed ID: 3236561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser photocoagulation versus combined laser photocoagulation and posterior sub-Tenon's triamcinolone injection for the primary treatment of diffuse diabetic macular edema.
    Rahman Mahdy RA; Saleh MM; Almasalamy SM
    Cutan Ocul Toxicol; 2010 Jun; 29(2):91-7. PubMed ID: 20151875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal observation of subretinal fibrosis in Vogt-Koyanagi-Harada disease.
    Zhao C; Dong F; Gao F; Liu X; Pei M; Jia S; Zhang M
    BMC Ophthalmol; 2018 Jan; 18(1):6. PubMed ID: 29334924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Value of Optical Coherence Tomography in the Early Diagnosis of Macular Complications in Chronic Vogt-Koyanagi-Harada Disease.
    Agarwal M; Radosavljevic A; Patnaik G; Rishi E; Pichi F
    Ocul Immunol Inflamm; 2022 May; 30(4):801-808. PubMed ID: 33136534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Edema of the photoreceptor layer in Vogt-Koyanagi-Harada disease observed using high-resolution optical coherence tomography.
    Lee JE; Park SW; Lee JK; Choi HY; Oum BS; Kim HW
    Korean J Ophthalmol; 2009 Jun; 23(2):74-9. PubMed ID: 19568354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anterior ischemic optic neuropathy associated with Vogt-Koyanagi-Harada disease.
    Nakao K; Mizushima Y; Abematsu N; Goh N; Sakamoto T
    Graefes Arch Clin Exp Ophthalmol; 2009 Oct; 247(10):1417-25. PubMed ID: 19568763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subretinal neovascular membranes in Vogt-Koyanagi-Harada syndrome.
    Moorthy RS; Chong LP; Smith RE; Rao NA
    Am J Ophthalmol; 1993 Aug; 116(2):164-70. PubMed ID: 8352300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment.
    Attia S; Khochtali S; Kahloun R; Ammous D; Jelliti B; Ben Yahia S; Zaouali S; Khairallah M
    Int Ophthalmol; 2016 Feb; 36(1):37-44. PubMed ID: 25939987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pars plana vitrectomy for intraocular inflammation-related cystoid macular edema unresponsive to corticosteroids. A preliminary study.
    Dugel PU; Rao NA; Ozler S; Liggett PE; Smith RE
    Ophthalmology; 1992 Oct; 99(10):1535-41. PubMed ID: 1454319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Central Macular Thickness and Retinal Nerve Fiber Layer Thickness in Eyes with Vogt-Koyanagi-Harada Disease: A 2-Year Follow-Up Study.
    Han YS; Shin KS; Lee WH; Kim JY
    Ophthalmologica; 2018; 239(2-3):143-150. PubMed ID: 29339644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multispectral image analysis in Vogt-Koyanagi-Harada disease.
    Huang G; Peng J; Ye Z; Kijlstra A; Zhang D; Yang P
    Acta Ophthalmol; 2018 Jun; 96(4):411-419. PubMed ID: 29220112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomography.
    Ishihara K; Hangai M; Kita M; Yoshimura N
    Ophthalmology; 2009 Sep; 116(9):1799-807. PubMed ID: 19643489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal cystoid spaces in acute Vogt-Koyanagi-Harada syndrome.
    Tsujikawa A; Yamashiro K; Yamamoto K; Nonaka A; Fujihara M; Kurimoto Y
    Am J Ophthalmol; 2005 Apr; 139(4):670-7. PubMed ID: 15808163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macular Abnormalities in Vogt-Koyanagi-Harada Disease.
    Yang P; Ye Z; Xu J; Du L; Zhou Q; Qi J; Liang L; Wang C; Zhou C; Cao Q; Wu L; Kijlstra A
    Ocul Immunol Inflamm; 2019; 27(8):1195-1202. PubMed ID: 31415220
    [No Abstract]   [Full Text] [Related]  

  • 19. Annular choroidal detachment in a patient with Vogt-Koyanagi-Harada disease.
    Yamamoto N; Naito K
    Graefes Arch Clin Exp Ophthalmol; 2004 Apr; 242(4):355-8. PubMed ID: 14963715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease.
    Inomata H; Rao NA
    Am J Ophthalmol; 2001 May; 131(5):607-14. PubMed ID: 11336935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.